Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows